Journal ArticleDOI
TFOS DEWS II Sex, Gender, and Hormones Report
David A. Sullivan,Eduardo Rocha,Pasquale Aragona,Janine A. Clayton,Juan Ding,Blanka Golebiowski,Ulrike Hampel,Alison M. McDermott,Debra A. Schaumberg,Debra A. Schaumberg,Sruthi Srinivasan,Piera Versura,Mark D. P. Willcox +12 more
TLDR
Overall, sex, gender and hormones play a major role in the regulation of ocular surface and adnexal tissues, and in the difference in DED prevalence between women and men.Abstract:
One of the most compelling features of dry eye disease (DED) is that it occurs more frequently in women than men. In fact, the female sex is a significant risk factor for the development of DED. This sex-related difference in DED prevalence is attributed in large part to the effects of sex steroids (e.g. androgens, estrogens), hypothalamic-pituitary hormones, glucocorticoids, insulin, insulin-like growth factor 1 and thyroid hormones, as well as to the sex chromosome complement, sex-specific autosomal factors and epigenetics (e.g. microRNAs). In addition to sex, gender also appears to be a risk factor for DED. "Gender" and "sex" are words that are often used interchangeably, but they have distinct meanings. "Gender" refers to a person's self-representation as a man or woman, whereas "sex" distinguishes males and females based on their biological characteristics. Both gender and sex affect DED risk, presentation of the disease, immune responses, pain, care-seeking behaviors, service utilization, and myriad other facets of eye health. Overall, sex, gender and hormones play a major role in the regulation of ocular surface and adnexal tissues, and in the difference in DED prevalence between women and men. The purpose of this Subcommittee report is to review and critique the nature of this role, as well as to recommend areas for future research to advance our understanding of the interrelationships between sex, gender, hormones and DED.read more
Citations
More filters
Journal ArticleDOI
TFOS DEWS II pathophysiology report
Anthony J. Bron,Anthony J. Bron,Cintia S. de Paiva,Sunil K. Chauhan,Stefano Bonini,Eric E. Gabison,Sandeep Jain,Erich Knop,Maria Markoulli,Yoko Ogawa,Victor L. Perez,Yuichi Uchino,Norihiko Yokoi,Driss Zoukhri,David A. Sullivan +14 more
TL;DR: The TFOS DEWS II Pathophysiology Subcommittee reviewed the mechanisms involved in the initiation and perpetuation of dry eye disease, finding the targeting of the terminal duct in meibomian gland disease and the influence of gaze dynamics and the closed eye state on tear stability and ocular surface inflammation to be important.
Journal ArticleDOI
TFOS DEWS II Management and Therapy Report
Lyndon Jones,Laura E Downie,Donald R. Korb,Jose M. Benitez-del-Castillo,Reza Dana,Sophie X. Deng,Pham N. Dong,Gerd Geerling,Richard Y Hida,Yang Liu,Kyoung Yul Seo,Joseph Tauber,Tais Hitomi Wakamatsu,Jianjiang Xu,James S. Wolffsohn,Jennifer P. Craig +15 more
TL;DR: It became clear that many of the treatments available for the management of dry eye disease lack the necessary Level 1 evidence to support their recommendation, often due to a lack of appropriate masking, randomization or controls and in some cases due to issues with selection bias or inadequate sample size.
Journal ArticleDOI
TFOS DEWS II Tear Film Report
Mark D. P. Willcox,Pablo Argüeso,Georgi As. Georgiev,Juha M. Holopainen,Gordon W. Laurie,Tom J. Millar,Eric B. Papas,Jannick P. Rolland,Tannin A. Schmidt,Ulrike Stahl,Tatiana Suarez,Lakshman N. Subbaraman,Ömür Ö. Uçakhan,Lyndon Jones +13 more
TL;DR: The members of the Tear Film Subcommittee reviewed the role of the tear film in dry eye disease (DED), biophysical and biochemical aspects of tears and how these change in DED and recommended areas for future research.
Journal ArticleDOI
TFOS DEWS II Report Executive Summary
Jennifer P. Craig,J. Daniel Nelson,J. Daniel Nelson,Dimitri T. Azar,Carlos Belmonte,Anthony J. Bron,Anthony J. Bron,Sunil K. Chauhan,Cintia S. de Paiva,José Álvaro Pereira Gomes,Katherine M. Hammitt,Lyndon Jones,Jason J. Nichols,Kelly K. Nichols,Gary D. Novack,Gary D. Novack,Fiona Stapleton,Mark D. P. Willcox,James S. Wolffsohn,David A. Sullivan +19 more
TL;DR: This article presents an Executive Summary of the conclusions and recommendations of the 10-chapter TFOS DEWS II report.
Journal ArticleDOI
TFOS DEWS II iatrogenic report.
José Álvaro Pereira Gomes,Dimitri T. Azar,Christophe Baudouin,Nathan Efron,Masatoshi Hirayama,Jutta Horwath-Winter,Terry Kim,Jodhbir S. Mehta,Elisabeth M. Messmer,Jay S. Pepose,Virender S Sangwan,Alan L. Weiner,Steven E. Wilson,James S. Wolffsohn +13 more
TL;DR: This report presents future directions to address iatrogenic DED, including the need for more in-depth epidemiological studies about the risk factors, development of less toxic medications and preservatives, as well as new techniques for less invasive eye surgeries.
References
More filters
Journal ArticleDOI
Gender difference in the non-specific and specific immune response in humans.
TL;DR: Insight in the sex differences of the basic non‐specific and specific immune response is obtained in the ex vivo study of the immune response of the female immune system.
Journal ArticleDOI
Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
Ian F. Godsland,K.F. Gangar,Christopher Walton,M. P. Cust,Malcolm Whitehead,Victor Wynn,John C. Stevenson +6 more
TL;DR: Neither treatment caused significant insulin resistance compared with baseline, but with the oral treatment insulin resistance was greater during the combined phase compared with the estrogen-only phase, Thus the oral regimen affected both insulin delivery and insulin resistance.
Journal ArticleDOI
The androgen receptor in health and disease.
Takahiro Matsumoto,Matomo Sakari,Maiko Okada,Atsushi Yokoyama,Sayuri Takahashi,Alexander Kouzmenko,Alexander Kouzmenko,Shigeaki Kato +7 more
TL;DR: This review summarized recent advances in understanding of the epigenetic mechanisms of AR action as well as newly recognized aspects of AR-mediated androgen signaling in both men and women offer a perspective on the use of animal genetic model systems aimed at eventually developing novel therapeutic AR ligands.
Journal ArticleDOI
Androgen replacement therapy in male patients with rheumatoid arthritis.
TL;DR: Seven men with active RA were treated daily for 6 months with oral testosterone undecanoate plus a nonsteroidal antiinflammatory drug in an attempt to evaluate the immunologic response, the overall clinical response, and the sex hormone response to such replacement therapy.
Journal ArticleDOI
Antimicrobial compounds in tears.
TL;DR: This review describes both classic antimicrobial compounds found in tears such as lysozyme and some more recently identified such as members of the cationic antimicrobial peptide family and surfactant protein-D as well as potential new candidate molecules that may contribute to antimicrobial protection.